Open AccessAbstract CT163: Temsirolimus in combinaton with metformin in patients with advanced or refractory endometrial cancers
Author(s) -
Aung Naing,
Daniel D. Karp,
Sarina A. PihaPaul,
Shubham Pant,
Vivek Subbiah,
Diane C. Bodurka,
Siqing Fu,
Amir A. Jazaeri,
Shumei Kato,
Kathleen M. Schmeler,
Alpa M. Nick,
Youngik Yang,
Fechukwu Akhmedzhanov,
S. N. Fessahaye,
Jing Gong,
Bettzy Stephen,
Amber Johnson,
Pamela T. Soliman,
Anil K. Sood,
Funda MericBernstam,
Karen H. Lu
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct163
Subject(s) - temsirolimus , medicine , mucositis , endometrial cancer , adverse effect , gastroenterology , metformin , oncology , cancer , anemia , toxicity , pi3k/akt/mtor pathway , apoptosis , biochemistry , insulin , discovery and development of mtor inhibitors , chemistry